Mark P. Joing
Director of Finance/CFO at SANY HEAL
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sandra Shpilberg | F | 48 |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | 5 years |
| Elisabeth Sandoval | F | 62 | 5 years | |
| Barbara Nelsen | F | 62 | - | |
| Timothy Zanni | M | 63 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ted Love | M | 65 |
Nuvelo, Inc.
| 8 years |
| Gary Titus | M | 64 |
Nuvelo, Inc.
| 3 years |
| Elias Bendekgey | M | 66 |
Nuvelo, Inc.
| 5 years |
| Jan Johansson | M | - |
Nuvelo, Inc.
| 1 years |
| Kim Popovits | F | 65 |
Nuvelo, Inc.
| 4 years |
| Paul S. Kwon | M | 53 |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | 5 years |
| Kirk James Hayenga | M | - |
Nuvelo, Inc.
| 6 years |
| Shelly Guyer | F | 63 |
Nuvelo, Inc.
| 1 years |
| S. Michael Imperiale | M | - |
Nuvelo, Inc.
| 3 years |
| Luis Peña | M | 61 |
Nuvelo, Inc.
| 4 years |
| Jill M. Pergande | F | - |
Nuvelo, Inc.
| 3 years |
| Gregory S. Yedinak | M | - |
Nuvelo, Inc.
| 3 years |
| Steven R. Deitcher | M | 59 |
Nuvelo, Inc.
| 3 years |
| Simon Allen | M | 56 |
Nuvelo, Inc.
| 2 years |
| Linda Fitzpatrick | F | 67 |
Nuvelo, Inc.
| 4 years |
| James R. Gavin | M | 78 |
Nuvelo, Inc.
| 3 years |
| Barry Zubrow | M | 70 |
Nuvelo, Inc.
| 3 years |
| Michael D. Levy | M | 63 |
Nuvelo, Inc.
| 4 years |
| Martin Vogelbaum | M | 60 |
Nuvelo, Inc.
| 8 years |
| Peter García | M | 62 |
Nuvelo, Inc.
| 3 years |
| Thomas N. McCarter | M | 93 |
Nuvelo, Inc.
| 8 years |
| Dennis Fenton | M | 72 |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | - |
| Burton E. Sobel | M | 86 |
Nuvelo, Inc.
| 5 years |
| Henry Ward Wolff | M | 75 |
Nuvelo, Inc.
| 1 years |
| George B. Rathmann | M | - |
Nuvelo, Inc.
| 6 years |
| Raymond Steitz | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 30 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark P. Joing
- Personal Network
